$SUND
Sundance Strategies, Inc.

2023 Q1 Form 10-Q Financial Statement

#000149315223004805 Filed on February 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $157.6K $149.2K $149.1K
YoY Change 25.08% 0.05% -46.24%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $157.6K $149.1K $149.1K
YoY Change 25.09% 0.04% -46.24%
Operating Profit -$149.2K -$149.1K
YoY Change 0.05%
Interest Expense -$62.09K $131.3K -$81.45K
YoY Change -66.02% -261.15% -64.39%
% of Operating Profit
Other Income/Expense, Net -$522.7K -$81.45K
YoY Change 541.77%
Pretax Income -$1.588M -$671.9K -$230.5K
YoY Change -27.13% 191.44% -51.93%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.588M -$671.9K -$230.5K
YoY Change -27.13% 191.44% -51.93%
Net Earnings / Revenue
Basic Earnings Per Share -$0.02 -$0.01
Diluted Earnings Per Share -$0.04 -$0.02 -$5.577K
COMMON SHARES
Basic Shares Outstanding 41.41M shares 41.41M shares 41.33M shares
Diluted Shares Outstanding 41.41M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $550.00 $3.160K $53.39K
YoY Change -99.79% -94.08% -71.42%
Cash & Equivalents $550.00 $3.158K $53.39K
Short-Term Investments
Other Short-Term Assets $8.300K $11.85K $13.87K
YoY Change 1.59% -14.56% 13.04%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.850K $15.01K $67.27K
YoY Change -96.8% -77.69% -66.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $2.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $8.850K $15.01K $67.27K
Total Long-Term Assets $0.00 $2.00 $0.00
Total Assets $8.850K $15.01K $67.27K
YoY Change -96.79% -77.69% -66.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $753.1K $698.8K $557.5K
YoY Change 29.62% 25.34% -17.47%
Accrued Expenses $574.6K $514.9K $315.3K
YoY Change 62.21% 63.29% 155.81%
Deferred Revenue
YoY Change
Short-Term Debt $300.0K $300.0K $300.0K
YoY Change 0.0% 0.0%
Long-Term Debt Due $876.0K $717.1K $876.0K
YoY Change 0.0% -18.14% 6.05%
Total Short-Term Liabilities $2.904M $2.631M $2.449M
YoY Change 15.63% 7.43% 20.94%
LONG-TERM LIABILITIES
Long-Term Debt $2.281M $2.238M $2.026M
YoY Change 7.32% 10.46% 5.74%
Other Long-Term Liabilities $857.7K $807.8K $621.1K
YoY Change 28.78% 30.06% 22.22%
Total Long-Term Liabilities $3.139M $3.046M $2.647M
YoY Change 12.44% 15.06% 9.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.904M $2.631M $2.449M
Total Long-Term Liabilities $3.139M $3.046M $2.647M
Total Liabilities $6.043M $5.676M $5.096M
YoY Change 13.95% 11.39% 14.54%
SHAREHOLDERS EQUITY
Retained Earnings -$35.06M -$33.47M
YoY Change 8.72%
Common Stock $41.41K $41.41K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.034M -$5.661M -$5.029M
YoY Change
Total Liabilities & Shareholders Equity $8.850K $15.01K $67.27K
YoY Change -96.8% -77.69% -66.21%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.588M -$671.9K -$230.5K
YoY Change -27.13% 191.44% -51.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$82.90K -$109.3K -$147.5K
YoY Change -55.29% -25.9% -59.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.30K 112.0K 200.0K
YoY Change -79.93% -44.0% -63.36%
NET CHANGE
Cash From Operating Activities -82.90K -109.3K -147.5K
Cash From Investing Activities
Cash From Financing Activities 80.30K 112.0K 200.0K
Net Change In Cash -2.600K 2.660K 52.45K
YoY Change -101.21% -94.93% -71.55%
FREE CASH FLOW
Cash From Operating Activities -$82.90K -$109.3K -$147.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei City Area Code
CityAreaCode
(801)
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50547
dei Entity Registrant Name
EntityRegistrantName
SUNDANCE STRATEGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0515333
dei Entity Address Address Line1
EntityAddressAddressLine1
4626 North 300 West
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite No. 365
dei Entity Address City Or Town
EntityAddressCityOrTown
Provo
dei Local Phone Number
LocalPhoneNumber
717-3935
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SUND
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41408441 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3158 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267966 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
11850 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
8167 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
15008 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
276133 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
698797 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
580972 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
514916 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
354205 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
300000 usd
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
300000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001171838
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Investment Income Net
InvestmentIncomeNet
usd
CY2021Q4 us-gaap Investment Income Net
InvestmentIncomeNet
usd
us-gaap Investment Income Net
InvestmentIncomeNet
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
717058 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
876000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
807826 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
666015 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2237808 usd
CY2022Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2125808 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3045634 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2791823 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5676405 usd
CY2022Q1 us-gaap Liabilities
Liabilities
5303000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
CY2021Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
SUND Issued Warrants As Debt Issuance Costs
IssuedWarrantsAsDebtIssuanceCosts
usd
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84604
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41408441 shares
CY2022Q4 SUND Stock Repurchase Payable Current
StockRepurchasePayableCurrent
400000 usd
CY2022Q1 SUND Stock Repurchase Payable Current
StockRepurchasePayableCurrent
400000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2630771 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2511177 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41408441 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41408441 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41408441 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
41409 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
41409 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27771476 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27181618 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33474282 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32249894 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5661397 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5026867 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15008 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
276133 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
149158 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
149086 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
524649 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
564691 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-149158 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-149086 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-524649 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-564691 usd
CY2022Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-377936 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-377936 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
285192 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
131257 usd
CY2021Q4 us-gaap Interest Expense
InterestExpense
71245 usd
us-gaap Interest Expense
InterestExpense
281303 usd
us-gaap Interest Expense
InterestExpense
204982 usd
CY2022Q4 us-gaap Financing Interest Expense
FinancingInterestExpense
13500 usd
CY2021Q4 us-gaap Financing Interest Expense
FinancingInterestExpense
10200 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
40500 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
97761 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-522693 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81445 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-699739 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17551 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-671851 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-230531 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1224388 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-582242 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4149 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-671851 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-230531 usd
us-gaap Net Income Loss
NetIncomeLoss
-1224388 usd
us-gaap Net Income Loss
NetIncomeLoss
-586391 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41408441 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41333224 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41408441 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41168876 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5026867 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-301596 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5328463 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6531437 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-250941 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5579404 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
211922 usd
CY2022Q4 SUND Warrants Issued In Connection To Extinguishment Of Debt
WarrantsIssuedInConnectionToExtinguishmentOfDebt
377936 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-671851 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5661397 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4716062 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55440 usd
CY2022 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.40 pure
CY2022Q2 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
1.05
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.05
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-101215 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4761837 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18480 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-254645 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-4998002 usd
CY2021Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
200000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-230531 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5028533 usd
us-gaap Net Income Loss
NetIncomeLoss
-1224388 usd
us-gaap Net Income Loss
NetIncomeLoss
-586391 usd
us-gaap Share Based Compensation
ShareBasedCompensation
73920 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
285192 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-377936 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52980 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3683 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4479 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
117825 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-50961 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
302522 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
225317 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-376808 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-627786 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
112000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
160000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
300000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
112000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
660000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-264808 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32214 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
267966 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21179 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3158 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53393 usd
SUND Issued Warrants As Debt Issuance Costs
IssuedWarrantsAsDebtIssuanceCosts
211922 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_842_eus-gaap--BasisOfAccounting_zhpiibgvtGG1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zI4XAHYf9ze7">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and reflect the financial position, results of operations and cash flows of the Company. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, which was filed with the SEC on June 29, 2022. The results from operations for the three and nine-month periods ended December 31, 2022, are not necessarily indicative of the results that may be expected for the fiscal year ended March 31, 2023. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, stockholders’ equity, and cash flows at June 30, 2022 and for all periods presented herein have been made.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s financial statements and the accompanying notes. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
589858 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0431 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.4223 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.4397 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
211922 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7873990 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4958754 shares
SUND Liquidity Requirements And Going Concern Disclosure Textblock
LiquidityRequirementsAndGoingConcernDisclosureTextblock
<p id="xdx_801_ecustom--LiquidityRequirementsAndGoingConcernDisclosureTextblock_zCe67b7wL9A5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(2) <span id="xdx_82C_zGPxMuxoU12">LIQUIDITY REQUIREMENTS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the Company’s inception on January 31, 2013, operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of December 31, 2022, the Company had $<span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20221231_zC9y5HrSQxO6" title="Cash">3,158</span> of cash assets, compared to $<span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20220331_zPpsgb9eqnKc" title="Cash">267,966</span> as of March 31, 2022. As of December 31, 2022, the Company had access to draw an additional $<span id="xdx_908_ecustom--AdditionalBorrowingCapacityFromRelatedPartyNotesPayable_iI_pp0p0_c20221231_z8HkyKJIJVBc" title="Additional borrowing capacity from related party notes payable">4,492,192</span> on the notes payable, related party (see Note 6) and $<span id="xdx_901_ecustom--AdditionalBorrowingCapacityOnConvertibleDebenture_iI_pp0p0_c20221231_zedbFzXWIDPj" title="Additional borrowing capacity from convertible debenture">3,000,000</span> on the Convertible Debenture Agreement (See Note 7). For the nine months ended December 31, 2022, the Company’s average monthly operating expenses were approximately $<span id="xdx_90F_eus-gaap--OperatingExpenses_pp0p0_c20220401__20221231_zDJx2iQrwZqh" title="Operating Expenses">58,500</span>, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and legal and accounting expenses. In addition to the monthly operating expenses, the Company continues to pursue other debt and equity financing opportunities, and as a result, financing expenses of $<span id="xdx_90C_eus-gaap--FinancingInterestExpense_pp0p0_c20221001__20221231_zUfiK4xCM072" title="Financing Interest Expense">13,500</span> were incurred during the three months ended December 31, 2022. As management continues to explore additional financing alternatives, beginning January 1, 2023, the Company is expected to spend up to an additional $<span id="xdx_90A_ecustom--AdditionalFinancingAlternatives_pp0p0_c20220401__20221231_zrSlaOZjE9ag" title="Additional financing alternatives">385,000</span>  on these efforts. Outstanding Accounts Payable as of December 31, 2022 totaled $<span id="xdx_904_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20221231_z4N9BYRBoxei" title="Accounts payable">698,797</span>. Management has concluded that its existing capital resources and availability under its existing convertible debentures and debt agreements with related parties will be sufficient to fund its operating working capital requirements for at least the next 12 months, or through February 2024. Related parties have given assurance that their continued support, by way of either extensions of due dates, or increases in lines-of-credit, can be relied on. As mentioned above, the Company also continues to evaluate other debt and equity financing opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The outbreak of COVID-19 originated in Wuhan, China, in December 2019 and has since spread to multiple countries, including the United States and several European countries. On March 11, 2020, the World Health Organization declared the outbreak a pandemic. The COVID-19 pandemic is affecting the United States and global economies and may affect the Company’s operations and those of third parties on which the Company relies. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic is difficult to assess or predict, the impact of the COVID-19 pandemic on the global financial markets may reduce the Company’s ability to access capital, which could negatively impact the Company’s short-term and long-term liquidity. The ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. The Company does not yet know the full extent of potential delays or impacts on its business, financing or other activities or on healthcare systems or the global economy as a whole. However, these effects could have a material impact on the Company’s liquidity, capital resources, operations and business and those of the third parties on which we rely.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUNDANCE STRATEGIES, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3158 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267966 usd
CY2022Q4 SUND Additional Borrowing Capacity From Related Party Notes Payable
AdditionalBorrowingCapacityFromRelatedPartyNotesPayable
4492192 usd
CY2022Q4 SUND Additional Borrowing Capacity On Convertible Debenture
AdditionalBorrowingCapacityOnConvertibleDebenture
3000000 usd
us-gaap Operating Expenses
OperatingExpenses
58500 usd
CY2022Q4 us-gaap Financing Interest Expense
FinancingInterestExpense
13500 usd
SUND Additional Financing Alternatives
AdditionalFinancingAlternatives
385000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
698797 usd
CY2018Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
6000000 shares
CY2018Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.05
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
52980 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-377936 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
7873990 shares
CY2022Q4 SUND Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
7873990 shares
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2022Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
3113808 usd
CY2022Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
3001808 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
287962 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 usd
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
124225 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
124225 usd

Files In Submission

Name View Source Status
0001493152-23-004805-index-headers.html Edgar Link pending
0001493152-23-004805-index.html Edgar Link pending
0001493152-23-004805.txt Edgar Link pending
0001493152-23-004805-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sund-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
sund-20221231_cal.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
sund-20221231_def.xml Edgar Link unprocessable
sund-20221231_lab.xml Edgar Link unprocessable
sund-20221231_pre.xml Edgar Link unprocessable